Working… Menu

A Study of Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03783923
Recruitment Status : Completed
First Posted : December 21, 2018
Last Update Posted : February 21, 2021
Information provided by (Responsible Party):
PTC Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 31, 2021
Actual Study Completion Date : January 31, 2021